Show simple item record

dc.contributor.authorBurns, Victoria
dc.contributor.authorMisra, Vivek
dc.contributor.authorPaton, Nina
dc.date.accessioned2020-06-16T11:03:15Z
dc.date.available2020-06-16T11:03:15Z
dc.date.issued2020en
dc.identifier.citationV. Burns, V. Misra and N. Paton. Systemic anti-cancer therapy delivery in the home: a service model. Br J Nurs. 2020;29(10):S22-S29.en
dc.identifier.pmid32463747en
dc.identifier.doi10.12968/bjon.2020.29.10.S22en
dc.identifier.urihttp://hdl.handle.net/10541/623031
dc.description.abstractThe Christie NHS Foundation Trust is a leader in adapting patient care in response to treatment advances and new patient-centred care/efficiency initiatives. Due to extended waiting times in cancer clinics, The Christie developed an at-home treatment service to help reduce the pressure on clinics and improve patient experience. This article provides a detailed examination of the requirements necessary to successfully develop a home service for the delivery of systemic anticancer treatment. The authors discuss the criteria used to identify suitable at-home treatments, as well as necessary resources and equipment. The success of the Christie at Home service was examined using a patient survey to assess the standard of this care. Details are given regarding the challenges of implementing a homecare service and potential future challenges. As an example, systemic treatment with eribulin as a 'Christie at Home' therapy demonstrates the practicalities of introduction of new therapies in a homecare service.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.12968/bjon.2020.29.10.S22en
dc.titleSystemic anti-cancer therapy delivery in the home: a service modelen
dc.typeArticleen
dc.contributor.departmentSACT Outreach Manager, The Christie NHS Foundation Trust, Manchester.en
dc.identifier.journalBritish Journal of Nursingen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record